Two variants on CYP3A43 were identified to be associated with Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor [11] and serum metabolite measurement [12] respectively. This evidence concerns the gene CYP3A43 and acute coronary syndrome.